Subunit b is part of the peripheral stalk, which stabilizes the F₁ headpiece and transmits rotational energy from the F₀ proton channel to the catalytic F₁ domain (α₃β₃γεδ) . In mycobacteria, the peripheral stalk includes subunits b, b', and δ, forming a distinct structure compared to canonical bacterial ATP synthases .
Mechanical Coupling: Anchors the F₁ domain to the F₀ sector, ensuring efficient energy transfer .
Regulatory Role: Interacts with subunit δ to modulate ATP synthase activity in response to cellular conditions .
Recombinant subunit b (atpF) is typically expressed in E. coli for structural, biochemical, or drug-interaction studies. While M. abscessus subunit b is not explicitly reported in the literature, analogous recombinant proteins from other mycobacteria (e.g., M. tuberculosis, M. smegmatis) are well-documented.
Bedaquiline Resistance: Mutations in subunit c (e.g., c.129G→A) reduce drug binding affinity to the F₀ sector .
Subunit ε: Structural studies reveal its role in coupling proton translocation to ATP synthesis, but no direct drug interactions are reported .
Despite its critical role, M. abscessus subunit b (atpF) remains understudied. Key areas for investigation include:
Structural Characterization: Cryo-EM or NMR studies to resolve interactions with subunits b', δ, and the F₀ sector.
Functional Studies: ATPase activity assays to probe subunit b’s role in energy coupling.
Drug Targeting: High-throughput screening for inhibitors targeting the peripheral stalk.
STRING: 561007.MAB_1449
The M. abscessus ATP synthase is a bipartite F₁F₀ complex consisting of a water-soluble F₁-sector and a membrane-embedded F₀-sector. The F₁-sector contains five subunits (α₃β₃γδε) and houses the catalytic sites for ATP synthesis. The F₀-sector comprises three subunits (ab₂c₈₋₁₅) and functions as an ion-conducting pathway . This enzyme complex couples proton translocation through the F₀-sector with ATP formation in the F₁-headpiece, with the central stalk subunits γ and ε mediating this coupling . The ATP synthase is essential for energy metabolism in M. abscessus, generating adenosine triphosphate as the major energy currency for cellular processes .
Subunit b (atpF) is part of the membrane-embedded F₀-sector of the ATP synthase, existing as a dimer (b₂) within the complex. While the search results don't specifically detail atpF interactions in M. abscessus, the general structural arrangement in mycobacterial ATP synthases indicates that subunit b serves as a critical stator component. It connects the membrane-embedded F₀-sector to the catalytic F₁-sector, interacting with both the a-subunit in the membrane and the δ-subunit in the F₁ region. This structural arrangement helps maintain the stationary components of the enzyme while allowing the central rotary elements (including the c-ring and γε-stalk) to rotate during catalysis .
Mutations in ATP synthase components can confer significant drug resistance in M. abscessus, particularly to bedaquiline (BDQ), a potent ATP synthase inhibitor. Specific single nucleotide polymorphisms (SNPs) in the atpE gene (encoding subunit c) lead to amino acid substitutions such as D29V and A64P, which confer high resistance to BDQ . These mutations likely interfere with drug binding to the ATP synthase c-ring.
The table below summarizes resistance rates conferred by atpE mutations in M. abscessus:
| Strain or plasmid | BDQ resistance rate (2 μg/ml) |
|---|---|
| Wild-type M. abscessus CIP104536ᵀ | <1.1 × 10⁻⁸ |
| pAtpE (wild-type) | <4.7 × 10⁻⁸ |
| pAtpE D29V | 5.6 × 10⁻⁵ |
| pAtpE A64P | 3.5 × 10⁻⁵ |
These resistance patterns demonstrate that single point mutations in atpE can increase resistance rates by approximately 1,000-fold . While the search results don't specifically address mutations in atpF, similar mechanisms could potentially apply, whereby mutations in critical regions of subunit b might affect drug binding or enzyme function if targeted by antimycobacterial compounds.
Bedaquiline (BDQ) inhibits the ATP synthase in M. abscessus by targeting the c subunit of the F₀-sector, specifically binding to a cleft located between adjacent c subunits in the C ring . This binding involves interactions with residues Glu61, Tyr64, and Asp28, with the bromoquinoline moiety of BDQ fitting into the cleft that encompasses the proton-binding site (Glu61) . BDQ treatment results in rapid ATP depletion in M. abscessus, confirming that F₀F₁ ATP synthase is its primary target .
For researchers studying atpF, this mechanism suggests that subunit b may also represent a potential drug target, particularly at interfaces where it interacts with other subunits. Understanding the structural relationship between subunit b and the c-ring could reveal whether allosteric effects from subunit b modifications might influence BDQ binding or c-ring function. Researchers might investigate whether mutations in atpF affect BDQ susceptibility indirectly through structural changes in the ATP synthase complex.
The catalytic cycle of ATP synthesis involves coordinated conformational changes throughout the ATP synthase complex. While the search results don't specifically detail atpF conformational changes in M. abscessus, the general mechanism suggests that subunit b serves as a relatively static component of the stator stalk, maintaining structural integrity during rotation of the central stalk subunits γ and ε .
During proton translocation through the F₀-sector, the c-ring rotates, driving the rotation of the γε-stalk within the α₃β₃ hexamer of the F₁-sector . This rotation induces conformational changes in the catalytic sites, cycling them through different nucleotide-binding states. Throughout this process, subunit b likely undergoes subtle conformational adjustments to accommodate the stresses imposed by the rotating components while maintaining the structural connection between F₀ and F₁ sectors.
To study these conformational changes experimentally, researchers could employ techniques such as:
Site-directed spin labeling coupled with electron paramagnetic resonance (EPR) spectroscopy
Förster resonance energy transfer (FRET) using strategically placed fluorophores
Cross-linking studies to capture different conformational states during the catalytic cycle
While the search results don't provide specific protocols for atpF expression and purification, they offer insights based on studies of other ATP synthase components. For recombinant expression of M. abscessus ATP synthase components, researchers have used solution NMR spectroscopy to resolve atomic structures, suggesting successful expression and purification strategies .
Based on established methods for mycobacterial proteins, researchers should consider the following approach:
Expression system selection: E. coli BL21(DE3) strains are commonly used for mycobacterial protein expression. Consider using codon-optimized synthetic genes to overcome codon usage bias.
Vector design: Incorporate affinity tags (His₆, GST, or MBP) for purification, with TEV protease cleavage sites for tag removal. Include solubility-enhancing fusion partners if atpF proves difficult to express in soluble form.
Expression conditions:
Induction: IPTG concentration of 0.5-1.0 mM
Temperature: 18-25°C for overnight expression to enhance proper folding
Media: Consider M9 minimal media supplemented with ¹⁵N-NH₄Cl and/or ¹³C-glucose for NMR studies
Purification strategy:
Initial IMAC (Immobilized Metal Affinity Chromatography) for His-tagged proteins
Tag cleavage followed by reverse IMAC
Size exclusion chromatography for final polishing
Buffer optimization to maintain stability (typically phosphate buffer with 100-300 mM NaCl, pH 7.0-8.0)
Stability assessment: Perform thermal shift assays to identify optimal buffer conditions for long-term storage.
Several complementary techniques can be employed to study interactions between atpF and other ATP synthase components:
Solution NMR spectroscopy: The search results indicate that solution NMR has been successfully used to resolve the atomic structure of M. abscessus subunit ε, making it a viable approach for atpF structural studies . NMR can detect changes in chemical shifts upon binding to interaction partners, providing insights into interaction interfaces.
Surface Plasmon Resonance (SPR): Immobilize purified atpF on a sensor chip and flow other ATP synthase components over the surface to measure binding kinetics and affinities.
Isothermal Titration Calorimetry (ITC): Determine thermodynamic parameters of binding interactions between atpF and other subunits.
Cross-linking coupled with mass spectrometry: Use chemical cross-linkers to capture protein-protein interactions, followed by mass spectrometric analysis to identify interaction sites.
Yeast two-hybrid or bacterial two-hybrid systems: For initial screening of potential interaction partners.
Co-immunoprecipitation: Using antibodies against atpF to pull down interacting partners from cell lysates.
Cryo-electron microscopy: For structural determination of larger assemblies containing atpF and its interaction partners.
When designing experiments to study these interactions, researchers should consider:
The membrane-associated nature of atpF and the potential need for detergents or nanodiscs
The possibility that some interactions may only form in the context of the larger ATP synthase complex
The dynamic nature of these interactions during the catalytic cycle
The search results demonstrate the successful use of site-directed mutagenesis to investigate functional domains in ATP synthase components, particularly in creating BDQ-resistant mutants . A similar approach can be applied to atpF:
Mutant design strategy:
Target conserved residues identified through sequence alignment across mycobacterial species
Focus on predicted interaction interfaces with other subunits
Create alanine scanning mutants for initial identification of functional regions
Design specific mutations based on structural predictions or homology models
Mutagenesis methodology:
PCR-based site-directed mutagenesis using complementary primers containing the desired mutation
Gibson Assembly or similar overlap extension methods for multiple mutations
Functional assessment:
ATP synthesis assays comparing wild-type and mutant proteins
ATP hydrolysis assays to assess reverse reaction
Protein-protein interaction studies with other ATP synthase components
Structural analysis using NMR or crystallography to detect conformational changes
Complementation studies:
Express mutated atpF in M. abscessus strains with depleted or deleted native atpF
Assess growth rates and ATP production in complemented strains
Test drug susceptibility profiles, particularly for ATP synthase inhibitors
This approach allows for systematic mapping of functional domains within atpF and identification of residues critical for ATP synthase assembly, stability, and function.
The search results describe successful use of solution NMR spectroscopy to resolve the atomic structure of M. abscessus subunit ε (Mabε) , providing a valuable methodological framework for atpF structural studies. Researchers should follow these steps for NMR data analysis:
Sample preparation:
Express ¹⁵N and/or ¹³C-labeled recombinant atpF
Optimize buffer conditions for stability during extended NMR experiments
Determine optimal protein concentration (typically 0.5-1 mM) for NMR studies
NMR experiment selection:
Begin with 2D experiments: ¹H-¹⁵N HSQC to assess sample quality
Proceed with 3D experiments for backbone assignment: HNCA, HN(CO)CA, HNCACB, CBCA(CO)NH
For side-chain assignments: HCCH-TOCSY, H(CCO)NH, C(CO)NH
For distance constraints: ¹⁵N-edited NOESY and ¹³C-edited NOESY
For dynamics studies: ¹⁵N-T₁, ¹⁵N-T₂, and {¹H}-¹⁵N NOE measurements
Data processing workflow:
Process raw data using NMRPipe or Topspin
Analyze processed spectra using CCPN Analysis, CARA, or Sparky
Perform sequential backbone assignment
Assign side-chain resonances
Collect and classify NOE distance restraints
Measure residual dipolar couplings (RDCs) if possible
Structure calculation:
Use CYANA, ARIA, or similar software for automated NOE assignment and structure calculation
Refine structures using XPLOR-NIH or CNS with explicit solvent refinement
Validate structures using PROCHECK-NMR and PSVS
Dynamics analysis:
Calculate order parameters (S²) from relaxation data
Identify regions of increased flexibility
Correlate dynamics with functional domains
Integration with other structural data:
Compare with homologous structures
Validate using computational modeling approaches
Integrate with results from other biophysical techniques
This analytical workflow allows for comprehensive characterization of atpF structure, providing insights into its functional domains and potential interaction interfaces.
The search results describe ATP depletion assays used to evaluate the effect of bedaquiline (BDQ) on M. abscessus ATP synthesis . Based on these methodologies, researchers should consider the following approach when comparing ATP depletion across different inhibitors:
Experimental design considerations:
Include appropriate controls: untreated cells, cells treated with known inhibitors (e.g., BDQ), and cells treated with antibiotics that don't target ATP synthase (e.g., amikacin)
Test multiple concentrations of each inhibitor to establish dose-response relationships
Perform time-course experiments to determine the kinetics of ATP depletion
Test both rough and smooth variants of M. abscessus, as they may show different susceptibilities
Standardization of methods:
Use consistent growth conditions for M. abscessus cultures
Standardize cell density across experiments (OD₆₀₀)
Use a validated ATP quantification method (e.g., luciferase-based assay)
Normalize ATP levels to cell number or protein content
Data analysis approach:
Calculate percentage ATP depletion relative to untreated controls
Determine IC₅₀ values for each inhibitor
Compare the rate of ATP depletion (initial velocity analysis)
Use statistical methods (ANOVA with post-hoc tests) to determine significant differences between inhibitors
Interpretation framework:
Consider that rapid ATP depletion (within 180 minutes) is indicative of direct ATP synthase inhibition
Slower depletion may suggest indirect effects or different mechanisms
Compare results with MIC values to correlate ATP synthase inhibition with growth inhibition
Consider the specificity of inhibition by testing effects on other mycobacterial and non-mycobacterial species
This approach provides a robust framework for comparing the efficacy and specificity of potential ATP synthase inhibitors, facilitating the identification of promising therapeutic candidates.
The search results include data on resistance frequencies for M. abscessus strains with mutations in ATP synthase components . Appropriate statistical methods for analyzing such data include:
Descriptive statistics:
Calculate mean, median, and range of resistance frequencies
Determine fold-changes in resistance frequencies relative to wild-type
Hypothesis testing:
Use Fisher's exact test for comparing resistance frequencies between strains
Apply Chi-square tests for independence when comparing multiple mutations
Consider Poisson distribution-based analyses for rare mutation events
Regression methods:
Logistic regression to model the probability of resistance based on various factors
Poisson regression for modeling mutation rates
Survival analysis:
Kaplan-Meier curves to visualize the emergence of resistance over time
Cox proportional hazards models to identify factors affecting resistance development
Specialized methods for single-case data:
For the specific data from search result showing resistance frequencies for different M. abscessus strains, researchers should:
Report both individual experiments and mean values
Calculate confidence intervals for resistance frequencies
Use Fisher's exact test to determine if differences between wild-type and mutant strains are statistically significant
Consider Bonferroni correction for multiple comparisons if testing several mutations
This statistical approach enables robust comparison of resistance frequencies across different ATP synthase mutations, facilitating the identification of residues critical for drug binding and potential resistance mechanisms.